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Introduction
Osteoarthritis (OA) is an aging-related disease that affects
not only hyaline articular cartilage but all structures of
weight-bearing joints. The disease process involves
changes in the subchondral bone1,2 and is often associated
with an inflammatory response3,4. The central pathogenic
events in OA are loss and abnormal remodeling of cartilage
extracellular matrix. Chondrocytes constitute the only cell
type of the articular cartilage. They maintain tissue homeo-
stasis, respond to injury and perform the cartilage remod-
eling process that characterizes OA. Previous concepts on
OA pathogenesis focused on the role of chondrocytes in
the degradation of the extracellular matrix. More recent
findings suggest that chondrocyte death and survival are
closely linked to cartilage matrix integrity. This review
discusses mechanisms and consequences of chondrocyte
death.
Forms of cell death
Cell death occurs in a variety of morphologic and mol-
ecular manifestations. Attempts have been made to classify
different forms of cell death and to reconcile descriptive
terminologies, which are either based on morphologic
observations or mechanism-oriented experimental findings.
Apoptosis and necrosis have been contrasted as mech-
anistically and morphologically distinct types of cell death,
but it is now clear that they share common features and
delineate a continuous spectrum of cell death modalities.
Apoptosis is a form of programmed cell death (PCD) and is
either physiologic (as during development) or pathologic.
Necrosis as the conceptual counterpart is the conse-
quence of a pathologic incident. Apoptosis and necrosis
comprise a partially overlapping spectrum of cellular
events5–8. Cell death can be initiated as apoptosis but be
diverted into pathways that create features of necrosis; this
has been termed aborted apoptosis. For example, depend-
ing on intracellular energy levels apoptosis induced by the
death receptor Fas (CD95) can become necrosis-like11,12.
However, apoptosis is regulated by cellular signaling sys-
tems that lead to the orderly disintegration of individual
cells. The cell remnants are packaged into small vesicles or
apoptotic bodies that are generally removed by phagocyto-
sis13. Unlike apoptosis, necrosis does not require activation
of specific intracellular signaling cascades, and is a form of
non-programmed or accidental cell death. A distinctive
feature of apoptotic cell death is the activation of caspases,
a class of cysteine proteases with specificity for aspartic
acid residues14. Although not all forms of PCD depend on
caspases, these proteases play pivotal roles in the initiation
as well as the execution phase of apoptotic programs15.
Criteria that distinguish apoptosis and necrosis are
summarized in Table I.
Oncosis has been proposed as a distinct form of cell
death. Although many of its features, such as increased
membrane permeability or cell and organelle swelling, are
similar to necrotic death it has been suggested to be a form
of PCD16,17. Conceptually, necrosis is defined as the final
stage of any form of cell death including oncosis and
apoptosis. The mechanisms leading to oncosis have not
been investigated in detail but some evidence suggests
that failure of ionic pumps and ATP depletion may be
among the initiators of oncosis16,18. A role for phospho-
lipase A2 has also been suggested19,20. In a recent study
crosslinking of porimin, a 110 kDa cell surface molecule
was shown to induce oncosis in lymphoid cells indicating
that oncosis, similar to certain forms of apoptosis, can
be mediated by receptor-elicited signal transduction
events21,22. Internucleosomal DNA fragmentation does not
occur during oncosis. Cell death resembling oncosis
has been observed in atherosclerotic lesions23 and in
ischemic heart disease24 and may also occur in bone and
cartilage25.
Structure-forming or developmental PCD can also be
the consequence of autophagy, a type of cell death that
appears to be mechanistically distinct from apoptosis and
dependent on vacuolar proteolysis. This type of cell death
may or may not involve caspase activation and DNA
degradation, and it has been speculated that auto-
phagy occurs in cells which contain a protein degradation
machinery similar to that usually associated with the lyso-
somes of phagocytic cells. The molecular mechanisms of
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autophagy have been investigated in yeast and homo-
logues of some of the involved genes are found in higher
organisms including humans (for a recent review see26).
Summary: cell death occurs in a wide variety of morpho-
logic manifestations. PCD can have features of necrosis or
apoptosis or both. So far, only the mechanistic details of
apoptosis have been characterized while relatively little
information is available on the mechanisms of necrosis,
oncosis and autophagy.
Mechanisms of apoptosis
Apoptosis can be divided into an initiation and execution
phase (Fig. 1). Diverse stimuli that affect either mito-
chondrial function or death receptor activity or that cause
endoplasmic reticulum (ER) stress can initiate apoptosis.
During the early stages of apoptosis the activation of
initiator caspases are activated. The execution phase re-
sults in the structural disintegration of the cell with cytoplas-
mic and nuclear material being packaged into apoptotic
bodies.
The regulated degradation of nuclear DNA as a hallmark
of apoptosis is an enzymatic process catalyzed by a
magnesium-dependent deoxyribonuclease called caspase-
activated deoxyribonuclease (CAD)27 or DNA fragmenta-
tion factor 40 (DFF40)28 and possibly by DNase I29. CAD
cleaves nuclear DNA within the histone H1-bound spacer
regions between nucleosomes, generating double-
stranded DNA fragments of multiples of 180 base pairs30.
Upon separation by gel electrophoresis these fragments
form the characteristic DNA ladder. Larger DNA fragments
of 50 to 300 kilobase pairs are also generated during
apoptosis31. This so-called domain sized DNA fragmenta-
tion can occur in the absence of internucleosomal DNA
cleavage and may suggest the presence of at least
one additional nuclease involved in the fragmentation of
genomic DNA during apoptosis.
Another key feature of apoptotic programs is the
activation of caspases. Caspase activity can be blocked
by inhibitor peptides specific for individual caspases or
by pan-caspase inhibitors such as z-VAD.fmk. Typically,
cleavage of DNA into nucleosomal DNA fragments can be
blocked by caspase inhibitors, although cells are not
always prevented from undergoing alternative forms of
PCD32. In the nucleus latent CAD forms an inhibitory
complex with the inhibitor of caspase-activated deoxy-
ribonuclease (ICAD) protein, also called DNA fragmenta-
tion factor 45 (DFF45). Activated caspase-3 cleaves
ICAD and facilitates the assembly of CAD into its active
form leading to the production of nucleosomal DNA
fragments33.
Recent evidence suggests that the digestion of ICAD and
apoptotic DNA laddering as well as cell death are not
always dependent on caspase activity as these events can
also be catalyzed in a caspase-independent manner by
granzyme B, a serine protease with specificity for aspartic
acid residues34. Caspase-independence of DNA fragmen-
tation has also been described for cell death mediated by
apoptosis inducing factor (AIF), a mitochondrial flavo-
protein that, upon induction of apoptosis, translocates to
the nucleus and induces stage I chromatin condensation
and domain sized DNA fragments35–37. The release of
mitochondrial AIF can, for example, be triggered by poly-
ADP ribose polymerase (PARP) activation in response to
DNA-damaging agents38. Several other studies demon-
strate that apoptosis-like PCD can occur without inter-
nucleosomal DNA cleavage9–11,31,32,39,40. B cell
lymphomal/leukemia-2 (Bcl-2) inhibits cell death in situa-
tions where PCD proceeds in a caspase-independent
manner, suggesting mitochondrial regulation or an involve-
ment of the endoplasmic reticulum (ER) in this type of cell
death41,42. A novel cell death pathway has been described
that leads specifically to the activation of caspase-12
localized to the ER43. This caspase is activated upon ER
stress, possibly by calpain in a calcium-dependent
manner44. A role for TNF receptor-associated factor-2
(TRAF-2), which interacts with procaspase-12 and induces
its clustering in response to ER stress has also been
suggested45. To date, the downstream effector molecules
of caspase-12 have not been identified. However, PARP
cleavage and chromatin condensation as a consequence
of ER stress have been demonstrated43.
Summary: these findings suggest that in some PCD
systems caspase activity and internucleosomal DNA frag-
mentation are dispensable downstream occurrences with
Table I
Distinguishing features of apoptosis and necrosis
Necrosis Apoptosis
Morphologic Features
+ Swelling of cytoplasm and mitochondria + Shrinking of cytoplasm and chromatin condensation
+ Non-specific karyolysis + Nuclear fragmentation
+ Total cellular disintegration without formation of vesicles + Formation of membrane enclosed structures (apoptotic bodies)
Physiologic Characteristics
+ Induced by non-physiologic stimuli + Induced by physiologic stimuli
+ Early loss of membrane integrity + Tightly regulated signaling events
+ No energy requirement + Energy dependent
+ Random digestion of nuclear DNA (leading to smear in agarose
gelelectrophoresis)
+ Enzymatically catalyzed changes of cell membrane (annexin V
binding)
+ DNA degradation occurs after membrane permeabilization + Orderly fragmentation of chromosomal DNA (DNA laddering)
+ Activation of caspases
+ Late loss of membrane integrity
Consequences
+ Affects groups of cells in a tissue + Affects individual cells
+ Associated with an inflammatory response + Phagocytosis by adjacent cells or macrophages
+ Disintegrating cells are phagocytosed by leukocytes + Typically not associated with an inflammatory response
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respect to the induction of cell death. In many cases,
however, these two events are tightly linked features of
apoptosis execution.
Methods for cell death detection
Cell death is usually assessed by measuring parameters
such as DNA degradation, disintegration of lipid bilayers,
mitochondrial activity or, in the case of adherent cells,
cell detachment (Table II). In tissues electron microscopy
represents a reliable tool for the identification and
ultrastructural characterization of apoptotic cells but it is not
suitable for quantification of apoptosis. Application of a
single technique is often not sufficient to definitively dis-
tinguish between apoptosis and necrosis. For example,
changes in membrane integrity that are associated with
the release of cytosolic components occur during late
Fig. 1. The initiation phase of PCD is triggered when death stimuli activate at least one of three distinct cell death pathways: the mitochondrial
pathway, the death receptor pathway or the ER stress pathway. These pathways generally lead to the activation of initiator caspases.
Caspase-dependent PCD is based on executioner caspases that cleave downstream substrates including ICAD. This causes the activation
of CAD and the cleavage of chromosomal DNA into small fragments, which can be detected by agarose gel electrophoresis as a ‘ladder’.
However, in certain instances the mitochondrial pathway can also cause cell death when caspase activity is blocked. In these cases the
execution phase of apoptosis is caspase-independent. For example: a caspase independent execution phase is triggered upon release of
apoptosis inducing factor (AIF) that is located between the inner and outer membrane of the mitochondria. Upon translocation to the nucleus
an unknown signaling cascade causes chromatin condensation and large scale degradation of chromosomal DNA and subsequently cell
death that is not inhibited by z-VAD.fmk. Another caspase independent execution pathway is based on granzyme B. Granzyme B generally
activates caspases but direct cleavage of ICAD has been demonstrated suggesting that the caspase-dependent amplification loop is
dispensable in granzyme B induced apoptosis. All pathways lead to the orderly disintegration of the cell.
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apoptosis as well as during the early stages of necrosis46.
The binding of annexin V to phosphatidylserine residues
can be seen in apoptotic as well as necrotic or oncotic cells
with partially disintegrated plasma membranes47,48. DNA
fragmentation is typically detected by conventional agarose
gel electrophoresis of purified nuclear DNA or by pulse field
electrophoresis. CAD-mediated internucleosomal DNA
cleavage leads to the characteristic electrophoretic pattern
referred to as ‘DNA laddering’, which distinguishes apopto-
sis from the random DNA degradation that occurs during
necrotic cell death.
While the isolation of DNA of chromosomal origin and the
detection of DNA laddering do not pose a technical problem
in cultured cells this is often difficult or impossible for
tissues such as cartilage. DNA cleavage in tissue sections
is detected by TdT-mediated dUTP nick end-labeling
(TUNEL). This immunhistochemical method is based on
the enzymatic labeling of 3′-hydroxyl groups of deoxyribose
using terminal deoxynucleotidyl transferase (TdT) and
deoxyuridine triphosphate (dUTP) coupled to biotin or
digoxygenin for antibody detection. However, free 3′-DNA
hydroxyl groups are also generated during random necrotic
DNA degradation. TUNEL is therefore not suitable to defini-
tively distinguish between apoptosis and necrosis49–52. In
addition, in cartilage sections the TUNEL technique may
yield false positive signals leading to an overestimation of
cell death53. Antibodies specific for active caspase-3 or
neoepitopes in cleaved caspase substrates such as the
85 kDa fragment of PARP have been used to identify
apoptotic cells in tissues, including cartilage54. This may be
a valuable tool for identifying apoptosis in cartilage when
used in combination with TUNEL.
Mitochondrial respiratory activity is an indirect indicator
of cell viability. The widely used 3-(4,5-dimethylthiazol-
2y1)-2-5-diphenyltetrazolium bromide (MTT) assay pro-
vides a colorimetric assessment of mitochondrial
dehydrogenase activity in cultured cells and is based on
the conversion of tetrazolium salts into formazan. Impair-
ment of oxidative phosphorylation does, however, not
necessarily lead to cell death. On the other hand, some
pro-apoptotic and anti-proliferative stimuli do not cause a
reduction of mitochondrial dehydrogenase activity55–58.
However, in combination with other viability assays or
cell counting the measurement of mitochondrial activity is
useful for assessing cell viability.
Summary: most commonly used cell death assays do not
distinguish between the various cell death modalities since
they measure variables common to different forms of cell
death. In order to reliably characterize the type of cell
death for a given cell-stimulus combination or tissue it is
necessary to apply a combination of methods measuring
morphological as well as mechanistic cell death
parameters.
Regulators of chondrocyte death
EXTRACELLULAR MATRIX COMPONENTS
Cell-matrix interactions have been shown to mediate
survival in anchorage-dependent cell types59. Apoptosis
resulting from a lack of cell adhesion was first demon-
strated for endothelial cells and termed ‘anoikis’ (the Greek
word for homelessness)60. This type of cell death may be
mediated by the CD95/CD95 ligand death receptor
system61–63 or by cytoskeletal reorganization leading to the
release of the pro-apoptotic BH3-only protein Bcl-2 modi-
fying factor (Bmf)64. Studies on chondrocyte death path-
ways have been conducted with animal and human
chondrocytes in monolayer culture or embedded into
agarose or alginate matrices. Loss of certain matrix com-
ponents by itself can cause chondrocyte death. In cartilage
of mice homozygous for targeted inactivation of the
collagen type IIA1 gene, a decrease in cell density
was associated with ultrastructural features similar to
apoptosis65. Increased TUNEL signals and degradation of
DNA isolated from knee cartilage were also observed,
supporting the notion that type II collagen is important for
chondrocyte survival in vivo. The survival-promoting effect
of extracellular matrix is in part mediated by integrins. The
11 integrin is a major collagen receptor that is expressed
in chondrocytes. In mice inactivation of the integrin 1 gene
was associated with more severe cartilage degradation,
glycosaminoglycan depletion and synovial hyperplasia
when compared to wild type mice. In these mice cartilage
cellularity was reduced and the frequency of apoptotic cells
Table II
Methods for the characterization of cell death
Cell death parameter Method Specific detection of apoptosis
+ Externalization of phosphatidyl serine Annexin V binding no
+ Release of cytosolic compounds 51Cr release, 3H-labeled proteins, enzymatic activities in
culture supernatants
no
+ Uptake of dyes Vital dyes (counting of cells) or fluorescent dyes for FACS no
+ DNA laddering Agarose gel electrophoresis yes
+ In situ DNA cleavage TUNEL no
+ Nuclear condensation and fragmentation DAPI yes
+ DNA degradation DNA content in sub G1 cells (FACS), agarose gel
electrophoresis, DNA fragmentation ELISA
no
+ Internucleosomal DNA fragmentation DNA fragmentation ELISA, agarose gel electrophoresis yes
+ Oxidative phosphorylation MTT, Alomar Blue no
+ Mitochondrial membrane polarization Aggregation, uptake, sequestration of fluorescent dyes no
+ Caspase activity Conversion of fluorogenic substrates yes
+ Caspase processing Western blot, immunhistochemistry yes
+ Cleavage of caspase substrates Western blot, immunhistochemistry yes
+ Loss of cell attachment Staining of cells with crystal violet or fluorescent
DNA-binding dyes
no
+ Cellular ultrastructure Electron Microscopy yes
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was increased66. Death of chondrocytes maintained in
suspension could be prevented by collagen and was
associated with integrin 1-dependent cell aggregation67.
In chicken sterna type X collagen deposition and chondro-
cyte survival were dependent on integrins containing the 2
and 3 or 1 subunits, indicating that integrin-matrix inter-
actions are required for chondrocyte developmental pro-
grams as well as survival68. Antibodies to the integrin
5-subunit induced death in freshly isolated human
chondrocytes69 and peptides containing the sequence
arginine-glycine-aspartic acid (RGD peptides) that interfere
with integrin-mediated matrix binding reduce MTT-oxidizing
activity in cultured chicken chondrocytes70. These findings
suggest a direct involvement of integrin-ligand interactions
in chondrocyte death. Hyaluronan also protects chondro-
cytes from death receptor induced apoptosis and this is
mediated via the CD44 receptor71.
In OA and aging cartilage extracellular matrix can be
enzymatically degraded or undergo posttranslational
modifications such as advanced glycation72,73 or tyrosine
nitrosylation74. It has been demonstrated that such altered
matrix induces chondrocyte responses that are not acti-
vated by the native intact molecules. Examples include the
29 kd fragment of fibronectin75 and advanced glycation end
products76, which induce inflammatory responses.
Summary: chondrocyte survival is regulated by the inter-
action of integrins with native cartilage matrix components.
While it is possible that chondrocyte survival is exclusively
promoted by the presence of native extracellular matrix the
role of altered extracellular matrix or fragments of matrix
proteins in promoting chondrocyte survival or inducing cell
death has yet to be investigated.
MECHANICAL INJURY
Mechanical stimuli represent important regulators of
chondrocyte function and induce inflammatory mediators
such as IL-177 and NO78, matrix metalloproteinases79 or
the release of proteoglycans from cartilage explants80.
Certain types of mechanical injury can also induce
chondrocyte death81. The average peak pressures gener-
ated at the tibial articular surface during normal walking
have been reported to be approximetely 4 MPa. This
suggests a physiological range of mechanical stress for
articular cartilage81 and is borne out by the report that
cyclic loading at 6.9 MPa produced rapid cartilage damage
(by 250 cycles), while less than 3.5 MPa did not produce
any mechanical damage even after 120,000 cycles of
compression82. The lower limit of pressures that caused
significant chondrocyte death after loads simulating single
impact has been reported to be between 15 MPa and
20 MPa81,83. At these impact loads a linear correlation is
seen with impact injury and percent chondrocyte death84.
The rate at which mechanical stress is applied also
determines the type and degree of cartilage damage and
chondrocyte death. For the same level of applied mech-
anical stress, higher rates of mechanical stress produced
more cartilage cracks with chondrocyte death mainly
localized to the cracks, whereas low rates of mechanical
stress produced a more diffuse distribution of chondrocyte
death without significant cracks80. The threshold for induc-
ing chondrocyte death by mechanical stress drops signifi-
cantly when the loading is cyclic. Cyclic loads produced
significant cell death above 3.5 MPa in human patellar
explants82, and 6 MPa in bovine explants85. Again, a strong
correlation was observed between chondrocyte death and
stress levels above 6 MPa85.
Attempts have been made to distinguish the type of
chondrocyte death in response to cartilage injury. A study in
which ex vivo bovine articular cartilage was assessed for
apoptotic and necrotic cell death following holmium:YAG
laser treatment suggests that TUNEL positive cells are not
necessarily apoptotic as plasma membrane disintegration
occurred before DNA fragmentation86. Tew et al. demon-
strated apoptosis and necrosis at the edges of surgically
created wounds in cartilage explants obtained from mature
and immature bovine metatarsal joints87. Loening et al.
reported apoptosis in calf cartilage explants in response to
injurious compression with stress levels as low as 4.5 MPa
when applied for six cycles of 25 min compression. A dose
response was seen with an increasing percentage of cells
staining positive for TUNEL with increasing stress levels.
This correlated with decomposition of biomechanical
properties of the injured cartilage88. A similar stress level-
dependent increase in the percentage of TUNEL positive
cells was reported in mature bovine femoral articular carti-
lage89 and human tibial and femoral articular cartilage90.
These in-vitro findings were substantiated by in-vivo re-
ports of apoptosis after impact injury in rabbit patellae89
and clinically, in arthroscopic cartilage biopsies of patients
with acute knee injury91.
A time course of progressive apoptosis has also been
reported after mechanical injury. Within 24 h after surgical
wounding TUNEL positive cells were seen in a band
adjacent to the edge of the wound in immature cartilage87.
The number of TUNEL positive cells increased up to the
fifth day after wounding. In mature cartilage, TUNEL posi-
tive cells did not appear in response to wounding until the
fifth day after injury. In human cartilage explants, the
earliest signs of apoptosis due to mechanical stress
appeared around 6 h after injury and the percentage of
apoptotic cells was shown to increase up to 7 days after
injury90. A pattern of progressive apoptosis may open a
window for therapeutic modulation of cell death.
Summary: in animal models as well as in human carti-
lage injurious compression causes chondrocyte death.
TUNEL positive cells can be detected shortly after injury.
This indicates that impact-induced chondrocyte death is
associated with DNA degradation.
NITRIC OXIDE
Nitric oxide (NO) is a modulator of several chondrocyte
functions and is spontaneously produced by OA cartilage
explants92. High levels are also released from cytokine-
activated normal cartilage and isolated chondrocytes93. NO
production has been linked to the induction of chondrocyte
death. Blanco et al. first reported that high concentrations
of the NO donor sodium nitroprusside (SNP) induced
apoptosis-like cell death in cultured human chondrocytes94.
However, IL-1, a stimulus of inducible nitric oxide syn-
thase (iNOS) expression and NO production in chondro-
cytes did not cause cell death94,95. But in combination with
an oxygen radical scavenger hypoploidy and DNA fragmen-
tation were observed. These effects were abrogated by a
specific inhibitor of iNOS activity indicating that apoptosis
induced by IL-1 was dependent on endogenous NO
generation and that the proapoptotic effect of NO could be
blocked by reactive oxygen species (ROS)94. It was pro-
posed that the balance between intracellular NO and ROS
may determine the type of chondrocyte death, with a low
concentration of ROS promoting apoptosis in the presence
of NO and a high concentration of ROS promoting necrosis.
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In cultured human chondrocytes IL-1 induces binding of
annexin V but cell death or a causal relationship between
NO generation and annexin V binding was not demon-
strated96. SNP increased caspase-3 activity about 2.5-fold
in human OA chondrocytes. A caspase-3 specific inhibitor
peptide caused a partial inhibition of nucleosomal DNA
fragmentation as analyzed by ELISA suggesting that cell
death and cleavage of chromosomal DNA induced by
exogenous NO in cultured chondrocytes may depend in
part on active caspase-397. However, caspase-3 process-
ing in response to SNP was not detected by immunoblot-
ting and a caspase-3-specific inhibitor peptide failed to
inhibit DNA degradation in cultured human chondrocytes98.
It was also observed that IL-1-induced NO can partially
inhibit internucleosomal DNA fragmentation and caspase-3
processing induced by CD95 activation and simultaneous
treatment with proteasome inhibitors99. This effect of
endogenous NO was mimicked by SNP. However, cell
death was not blocked suggesting that NO specifically
interferes with apoptosis execution but does not prevent
chondrocytes from undergoing a form of cell death that
does not require caspase-3 activation or internucleosomal
DNA fragmentation99.
In rabbit chondrocytes SNP induced p38 mitogen-
activated protein kinase-dependent cell death and this was
associated with enhanced caspase-3 activity, suggesting
apoptosis as the cell death modality100,101. However, NO
production as a result of adenovirus-mediated over-
expression of iNOS did not cause cell death in rabbit
chondrocytes102. There are no reports on the induction of
apoptosis by endogenous NO or NO donors in cartilage
explants. An in-vivo study in a canine model of OA showed
that oral application of the iNOS inhibitor L-NIL significantly
reduced the number of TUNEL positive cells in femoral
condyles54 but it is not clear whether this is directly related
to NO effects on cell survival or the result of protective
effects of L-NIL against cartilage degradation.
In certain cell types NO inhibits apoptosis through
S-nitrosylation of cysteine residues present in the catalytic
center of caspases as well as through a variety of additional
mechanisms103 while in other cell types exogenous or
endogenous NO are proapoptotic104. The mechanisms
responsible for these dual actions of NO in regulating
apoptosis are poorly defined.
In human chondrocytes the effects of NO-donors on cell
death are age-dependent: chondrocytes from older donors
show an increased ratio of oxidized glutathione to reduced
glutathione when compared to cells from younger donors.
This may cause cells from older donors to be more sus-
ceptible to oxidant stress and explain why chondrocytes
from older donors are more sensitive to nitric oxide donor-
induced death105.
Summary: in chondrocytes, NO is produced in response
to cytokines such as IL-1 but conclusive evidence for cell
death as a consequence of endogenous NO-production
has not been reported. In vitro studies using NO-donors
have demonstrated induction of cell death. However, the
mechanisms of NO donor-induced chondrocyte death vary
with experimental conditions.
DEATH RECEPTORS
Members of the TNF-receptor family are transmembrane
receptors that contain intracellular death domains and
activate apoptosis signaling pathways. Fas (CD95) is
expressed on the cell surface of cultured chondrocytes106
and its expression levels are modulated by the density of
the cell cultures107. Fas expression was demonstrated in
cartilage from normal as well as OA donors106,108. Fas
ligand (FasL, CD95L) expression in cartilage was not
detected by immunhistochemistry or reverse transcriptase-
polymerase chain reaction (RT-PCR)106. Fas activation by
an agonistic anti-Fas antibody (CH-11) leads to low levels
of apoptosis in cultured chondrocytes. In cartilage tissue
culture, antibody to Fas does not cause cell death, most
likely because the extracellular matrix prevents the anti-
body from interacting with the receptor. Alternatively,
chondrocytes may not respond to Fas stimulation when
anchored in native cartilage matrix as they are protected
from Fas-dependent apoptosis through survival signals
generated by the interaction of integrins or other cell
membrane receptors with extracellular matrix ligands.
Although this suggests that the Fas/FasL system by itself is
not a potent inducer of chondrocyte apoptosis, Fas may
trigger apoptosis in cartilage where matrix is degraded, or
effectively enhance chondrocyte death in combination with
other apoptosis promoting factors. When survival-
promoting activities were neutralized by proteasome
inhibitors in vitro, the Fas pathway induced apoptosis in a
greater number of chondrocytes109.
The TNF receptor and Fas are members of the same
gene family and TNF- can induce apoptosis in certain cell
types. TNF- mediated chondrocyte death has not been
conclusively established. Hypertrophic and non-
hypertrophic chondrocytes from chicken sterna appear to
be uniquely responsive to TNF-. When challenged with
TNF- these cells underwent death and activation of
interleukin-1-converting enzyme (ICE), a caspase not
directly related to apoptosis110. TNF- stimulation of cultured
human chondrocytes also led to a small increase in the
number of TUNEL positive cells111. Other studies detected
nucleosomal DNA fragmentation or large scale DNA degra-
dation in response to TNF- when the chondrocytes were
simultaneously treated with proteasome inhibitors109,112.
TNF- on its own had no effect. In a chondrocytic cell line
TNF- induced internucleosomal DNA cleavage and cell
death but only in the absence of serum113. These data
suggest that TNF- induces apoptosis in chondrocytes only
in the presence of additional pro-apoptotic stimuli or the
absence of survival-promoting factors.
Summary: Fas-activation induces limited apoptotic death
in cultured human chondrocytes while TNF- on its own
does not appear to affect human chondrocyte viability.
Apoptosis mediated by Fas or TNF receptor can be en-
hanced when chondrocytes are simultaneously treated with
inhibitors of cell survival functions.
MITOCHONDRIA
Mitochondria are central regulators of apoptosis (for
reviews see114–116). In rat OA cartilage as well as in human
OA, mitochondria undergo ultrastructural changes that can
be linked to different stages of cell death117. During bone
development mitochondria may also be involved in
chondrocyte death. In the avian growth plate mitochondria
show a maturation-dependent reduction of oxidative
phosphorylation118 but a causal relation between reduced
energy metabolism and chondrocyte death was not dem-
onstrated. The activity of respiratory chain complexes II
and III as well as the mitochondrial membrane potential are
significantly reduced in cultured human chondrocytes from
OA donors when compared to normal donors119. In cultured
rabbit chondrocytes NO donor treatment induced a loss of
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mitochondrial membrane potential and inhibition of ATP syn-
thesis. However, this functional impairment was not associ-
ated with cell death suggesting that NO affects energy
metabolism and other chondrocyte functions but not necess-
arily cell viability120. It is, of course, possible that energy-
compromised chondrocytes become sensitized to other
death inducers. Loss of mitochondrial function may also be
linked to NO production induced by inorganic phosphate
(Pi)121. A causal relationship between Pi, NO production,
and mitochondrial dysfunction in avian growth plate
chondrocytes has recently been suggested122 but no data
are available regarding this possible relationship in OA.
Summary: in OA as well as in hypertrophic growth plate
chondrocytes the functionality of mitochondria is impaired
and this may contribute to chondrocyte death.
P53 AND C-MYC
Several studies have analyzed the expression of the
apoptotic regulators p53 and c-myc in cartilage and their
correlation with the presence of apoptotic cells. Expression
of p53 was detected in mice in the hypertrophic zone of
Meckel’s cartilage123. No direct spatial or temporal corre-
lation was observed between the expression of p53 and the
presence of TUNEL positive cells. In p53 knockout mice no
significant effect on cell death in cartilage was detected124
although bone development was affected. However,
immobilized knees of wildtype mice showed enhanced
cartilage degeneration and increased cell death when com-
pared to p53 knockout mice. These findings suggest a
correlation between cartilage degeneration, cell death
and p53 expression under conditions of impaired joint
mobility125. p53 expression was not detected in costo-
sternal growth plate or bone of neonatal infants with a
gestation period of approximately 26 weeks126. In OA and
RA cartilage lesions the frequency of in situ nick end
labeling (ISNEL) positive cells correlated with p53 expres-
sion127. In cultured human chondrocytes hydrostatic press-
ure induced apoptosis and this was associated with
increased p53 mRNA and protein expression128. In cul-
tured rabbit chondrocytes NO donor treatment caused
induction of p53 via p38 MAP kinase and NFkappaB.
Ectopic expression of p53 enhanced NO donor-induced
cell death indicating that p53 might influence chondrocyte
survival functions in the presence of NO100.
In rat growth plates higher levels of c-myc were detected
in hypertrophic than in proliferating chondrocytes, indicat-
ing a role for c-myc in terminal chondrocyte differ-
entiation129. Subcellular localization also changed and
c-myc immunoreactivity was found in the nuclei of prolifer-
ating chondrocytes. It decreased in the nuclei of mature
chondrocytes and appeared in the cytoplasm. The s-myc
protein was expressed in rat embryo cells committed to
undergo differentiation into hypertrophic chondrocytes130.
c-myc immunoreactivity increased in fully differentiated
hypertrophic chondrocytes131. In rabbit growth plates
c-myc staining frequently colocalizes with cells showing
DNA strand breaks. In chicken overexpression of c-myc
interfered with limb development but increased apoptosis
was not observed132. In a canine model of OA intense
staining for c-myc was found in areas of cartilage ero-
sion133. In the lesions of RA and OA cartilage c-myc
expression correlated with ISNEL signals and the degree of
cartilage destruction127. In cultured human chondrocytes
apoptosis and c-myc expression could be induced by
hydrostatic pressure128.
Summary: p53 may be involved in the regulation of
developmental and disease-related chondrocyte death but
the precise mechanisms remain to be defined. There is
no direct evidence that c-myc influences chondrocyte sur-
vival or death.
APOPTOSIS INHIBITORS
The anti-apoptotic protein Bcl-2 is expressed in cartilage
and cultured chondrocytes. In normal cartilage Bcl-2 was
found in mid-zone chondrocytes while OA cartilage showed
increased staining adjacent to fibrillations134. Immunhisto-
chemical analysis demonstrated that Bcl-2 expression was
more prominent in normal than in OA cartilage108. Over-
expression of Bcl-2 protected rat chondrocytic cells from
undergoing apoptosis induced by retinoic acid or serum
withdrawal135. In cultured human chondrocytes Bcl-2
expression is induced by IL-1 and this may in part account
for the anti-apoptotic effects of this cytokine95. In OA
chondrocytes Bcl-2 expression was blocked by NO donors
and this might render these cells suceptible to apoptosis
involving the mitochondrial pathway97. Transgenic mice
overexpressing parathyroid hormone-related peptide
(PTHRP) have reduced levels of Bcl-2 expression and
show abnormal bone development, suggesting a relation
between PTHRP-dependent Bcl-2 expression and normal
skeletal development136. Cartilage from collagen type II
deficient mice also shows a marked decrease in Bcl-2
expression and increased cell death65.
Several other intracellular inhibitors of apoptosis signal-
ing cascades may mediate protective effects in chondro-
cytes including inhibitors of the catalytic activation of
caspases such as the inhibitor of apoptosis proteins (IAPs,
reviewed in137). Despite substantial expression of Fas in
cultured chondrocytes, activation of this death receptor
leads to only marginal and incomplete caspase-3 process-
ing109. This limited processing of caspase-3 is probably
due to potent inhibitory mechanisms blocking transduction
of the death signal upstream of or at the level of caspase-3
activation. Some evidence suggests that low expression of
caspase-8 and expression of Fas-associated death
domain-like interleukin-1beta-converting enzyme (FLICE)
inhibitory protein (FLIP) may in part be responsible for this
impairment of Fas signaling109,138.
In one study, specific inhibition of mitogen-activated
protein kinase kinase (MEK) led to a dose-dependent
increase in caspase-3 processing and apoptosis-like cell
death indicating that the MAP kinase extracellular signal-
regulated kinase 1/2 (ERK1/2) signaling pathway may have
apoptosis inhibitory functions in chondrocytes139.
Cytokines and growth factors also regulate chondrocyte
apoptosis and survival. Autocrine production of insulin-like
growth factor (IGF)-1 and -2 promoted survival of alginate-
embedded human chondrocytes in serum-free medium.
When the interaction of IGF with its receptor was blocked
by addition of an IGF receptor-specific antibody increased
caspase-3 activity and apoptosis were observed140. How-
ever, the effect of caspase inhibition on cell death was not
investigated in this study. Other cytokines also protect
chondrocytes from apoptosis, possibly through NF-kappaB
activation. This transcription factor is known to interfere
with apoptosis induction by TNF-141. In chondrocytes
NFkappaB is strongly activated by certain cytokines and
studies using inhibitors of NF-kappaB provide evi-
dence that it is, at least partially, involved in chondrocyte
protection from Fas and NO donor induced death95,97,142.
For example, IL-1 has anti-apoptotic activity with respect
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to Fas-induced apoptosis. This effect, which was abrogated
by inhibitors of tyrosine phosphorylation appears to
depend partly on the activation of NF-kappaB95. TNF- was
shown to mediate protection of chondrocytes from SNP-
induced cell death possibly through NF-kappaB and
cyclooxygenase 2 activity142.
Summary: in vitro studies indicate that anti-apoptotic
modulators such as NF-kappaB interfere with the induction
of cell death by Fas, TNF receptor, and NO donors. In
cultured chondrocytes, expression of the anti-apoptotic
protein Bcl-2 is influenced by inflammatory mediators while
the analysis of knockout mice suggests a role for PTHRP
as well as collagen type II in the regulation of Bcl-2
expression. In addition, cytokines can have anti-apoptotic
functions in certain experimental settings, probably through
effects on expression and/or activation of intracellular
apoptosis regulators.
Apoptosis in joint development
PCD of chondrocytes is an essential process in normal
skeletal development. In chicken embryos, cell death was
detected by TUNEL at very early stages of joint formation in
the developing anlagen143. In several electron and light
microscopic studies features of apoptosis were reported in
growth plate at the chondro-osseous junction144,145. In
chicken tibial growth plate, evidence of apoptotic cell death
was detected in the hypertrophic as well as the proliferative
zone by TUNEL and ultrastructural analysis146.
The type of this developmentally restricted cell death
may be apoptosis but this has been challenged by the
discovery of ‘dark’ chondrocytes, which do not display
the typical ultrastructural features of apoptotic cells. In the
avian epiphysis ‘dark’ chondrocytes undergo a hybrid form
of cell death, which has ultrastructural characteristics of
apoptosis as well as necrosis. This type of cell death may
be associated with abnormalities in the cell cycle147,148.
Another unusual type of epiphyseal chondrocytes are
‘paralyzed’ cells, which also display ultrastructural features
that are different from apoptosis149. Dark chondrocytes and
paralyzed chondrocytes have also been observed in the
chondroepiphysis of rabbits150. These findings suggest that
developmental chondrocyte death may represent a modi-
fied form of cell death distinct from apoptosis or necrosis,
which may have developed as an adaptation to the specific
conditions of cartilage tissue.
Chondrocyte death in growth plate is part of the
developmental extracellular matrix remodeling process.
Deposition of calcified matrix adjacent to the hypertrophic
zone151,152 was accompanied by vascular invasion and
chondrocyte death suggesting a causal link between local
elevation of calcium levels and developmental chondrocyte
death. Matrix vesicles are membrane-enclosed particles
released by differentiating growth plate chondrocytes at
sites of initial calcification153. Based on functional simi-
larities between matrix vesicles and apoptotic bodies154, it
is possible that the generation of matrix vesicles in growth
plates is at least in part related to programmed chondrocyte
death. A link between chondrocyte death and vascular
invasion has also been suggested. In mice with targeted
inactivation of the gelatinase B (MMP-9) gene, vasculariz-
ation of the growth plate and apoptosis of hypertrophic
chondrocytes were delayed. This indicates that chondro-
cyte apoptosis during endochondral bone formation may be
regulated by MMP-9-dependent angiogenesis. Alterna-
tively, MMP-9-dependent matrix degradation may cause
chondrocyte apoptosis, which triggers vascular invasion155.
Several studies have addressed potential regulators of
chondrocyte death in growth plate. Terminally differentiated
growth plate chondrocytes were shown to undergo a
maturation-dependent loss of mitochondrial function prior
to cell death118. Pi induced cell death in terminally differen-
tiated chondrocytes from chicken growth plates156. These
cells were uniquely susceptible since sternal chondrocytes
representing earlier developmental stages did not undergo
cell death in response to Pi. A similar selective sensitivity
was demonstrated for hypertrophic chondrocytes from
chicken tibia, which underwent cell death when over-
expressing plasma transglutaminase, an enzyme with
protein-crosslinking activity. Non-hypertrophic chondro-
cytes transfected with the same construct did not undergo
cell death157. Mice with targeted inactivation of galectin 3,
a beta-galactoside-binding protein, showed increased
numbers of empty lacunae at the chondrovascular junction
as well as condensed chondrocytes in the hypertrophic
zone. This finding indicates a role for galectin 3 in
the regulation of epiphyseal chondrocyte death and
vascularization158.
Summary: chondrocyte death that is associated with
DNA degradation occurs in the growth plate as evidenced
by TUNEL staining. Ultrastructural analysis suggests a
form of cell death distinct from apoptosis or necrosis.
Chondrocyte death in the growth plate is linked to matrix
mineralization and vascular invasion. In vitro studies
suggest that Pi is an inducer of chondrocyte death.
Apoptosis in OA cartilage
Several studies have examined cell death in human
articular cartilage affected by OA53,96,108,127,159,162 or in
experimental OA models163. While most studies found
increased apoptotic cell death in OA cartilage, there was a
wide range in the reported frequencies of apoptotic cells.
An age-related increase in chondrocyte apoptosis has also
been reported164 and may account for the reduced carti-
lage cellularity that had been observed earlier165–167. In
human OA cartilage electron microscopy revealed nuclear
and cytoplasmic features consistent with apoptotic cell
death. The superficial zone of OA cartilage contained some
empty lacunae, lysosome-like structures, matrix vesicle-like
structures, fragmented chondrocytes, and nuclear conden-
sation159. In addition to cells with ultrastructural features of
apoptosis human OA cartilage also contains cells that
appear necrotic (Fig. 2). In OA, chondrocyte death was
correlated with age and disease severity. Within the same
joint, TUNEL positive cells were more frequent in cartilage
lesions than in non-lesional areas108 and cartilage areas
that contained TUNEL positive cells showed proteoglycan
depletion160. Since cartilage does not contain mononuclear
phagocytes and is avascular, dead cells or apoptotic bodies
are not removed but remain in the lacunae, where they
disintegrate and release their contents. Ultrastructural
evidence suggests that disintegration of chondrocytes in
articular cartilage may lead to the formation of membrane-
enclosed structures resembling matrix vesicles154,159,162.
These structures, which are remnants of dead cells may in
fact be apoptotic bodies and may contribute to matrix
mineralization or degradation in OA.
Apoptotic chondrocytes in the upper zone of osteo-
arthritic cartilage were associated with mineral deposits.
These needle-like mineral crystals were often associated
with matrix vesicles as seen in calcifying growth plate
cartilage suggesting that osteoarthritic chondrocytes may
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enter a differentiation state reminiscent of hypertrophy161. A
link between chondrocyte apoptosis and calcification has
also been observed in menisci from human OA joints168
where TUNEL positive cells were co-localized with strong
expression of enzymes that mediate calcium pyrophos-
phate dihydrate deposition (Fig. 3). In a rabbit model, in
which OA-like changes in cartilage were induced by
anterior cruciate ligament transection chondrocyte death
correlated with extracellular matrix degradation and NO
production163. In a canine OA model caspase-3 levels and
the number of TUNEL positive chondrocytes in tibial
plateus were increased significantly when compared to
untreated controls54. This also correlated with the histologic
severity of the lesions. A similar correlation of caspase-3
expression, OA grade and cell death has been reported for
human OA169.
Summary: cell death with features of apoptosis has been
detected in OA cartilage as well as animal models of OA.
This was associated with matrix degradation and calcifica-
tion, suggesting a role for cell death in OA pathogenesis.
Inducers and mechanisms of chondrocyte death in OA
cartilage have not been conclusively identified.
Prevention of chondrocyte apoptosis
Several applications of the therapeutic use of anti-
apoptotic agents have already been explored in neuro-
degenerative diseases, ischemia/reperfusion injury, and
autoimmune disorders. The key role that caspases play in
initiating and executing apoptosis make them prime targets
for apoptosis modulation. Some of the early reports of
Fig. 2. Chondrocyte death in OA cartilage. (A) The normal chondrocyte has a relatively large nucleus and small cytoplasmic volume. The cell
and cellular organelles are surrounded by intact membranes. The chromatin within the nucleus is evenly distributed. (B) The right cell shows
irregular chromatin with luscent vacuoles. Intact cellular organelles cannot be detected and the cytoplasma membrane is deteriorating but
there is no nuclear/cellular shrinkage. The chromatin is marginalized but not condensed or fragmented indicating necrosis-like cell death. In
contrast, the left cell (see also higher magnification in (C)) displays a highly condensed nucleus (arrow) and cell shrinkage indicative of
apoptosis. However, necrotic changes such as the formation of vacuoles, disruption of cellular organelles and cytoplasmic protrusions
(cones) are also evident. N, nucleus, C, cytoplasm.
Fig. 3. Localization of TUNEL-positive cells, calcium deposits and pyrophosphate-generating enzymes in menisci from OA-affected human
knees. The left panel shows apoptotic cells, many in clusters, in the vicinity of (alizarin red-positive) calcified areas. The right panel shows
cells immediately bordering calcifications. Staining for the pyrophosphate-producing enzymes PC-1, ATX and B10 is also prominent at sites
of calcification and in areas with TUNEL-positive cells.
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apoptosis inhibition were (1) expression of p53 to block
retinal cell apoptosis in Drosophila mutants170, (2) inhibition
of caspases to decrease neuronal cell death in mice171,
(3) and reduce ischemia/reperfusion induced damage of
cardiomyocytes in rats172. Several reports of varying
success with inhibition of apoptosis have been published
in models of various diseases affecting the central
nervous system173–176, liver177,178, heart179,180, lung181
and kidneys182.
Fewer reports are available regarding prevention of
apoptosis in chondrocytes. Nuttall et al. induced apoptosis
in immortalized human chondrocytes (via TNF-, stauro-
sporine, okadaic acid, and reduced serum) and reported
that non-specific caspase inhibition by the pan-caspase
inhibitor Z-VAD.fmk as well as specific inhibition of
caspase-3 by Ac-DMQD-CHO blocked apoptosis113.
D’Lima et al. reported chondrocyte apoptosis after mech-
anical injury to bovine and human articular cartilage
explants89,90. Caspase inhibition with Z-VAD.fmk sig-
nificantly reduced the percentage of cells undergoing
apoptosis183.
While caspase inhibition may prevent or reduce
apoptosis in chondrocytes, it has been shown that the
rescued cells are not always fully functional. Caspase
inhibition of spontaneous and drug-induced apoptosis in B
lymphocytes prevented apoptosis but resulted in
cell necrosis rather than cell survival184. In a model of
Parkinson’s disease, caspase inhibition via Z-VAD.fmk
blocked caspase activation and prevented apoptotic
cell death but did not restore neuronal functionality185.
Caspase activity was blocked by Z-VAD.fmk in neurons
exposed to colchicine, but the neurons underwent delayed
cell death186.
In contrast to these findings apoptosis inhibition was
associated with improved functional outcome in a variety of
disease models. Anti-apoptotic treatment prevented
blindness in Drosophila retinal degeneration mutants170,
reduced amebic liver abscess size178, improved myo-
cardial function in rat model of sepsis187, reduced myo-
cardial infarct size179,188, limited cerebral infarct size in
mice174, improved neurologic outcome in rats with cerebral
ischemia189, prolonged survival rates of mice with acute
lung injury181, and prevented inflammation after renal
ischemia-reperfusion injury182. Specific to chondrocytes,
the findings of Nuttal et al. suggest that caspase inhibition
retains functionality of the type II collagen promoter after
challenge with camptothecin or tumor necrosis factor-alpha
plus cycloheximide, two potent inducers of caspase-
dependent chondrocyte death. Reduction of cartilage
degeneration following caspase inhibition has also been
reported for a rabbit model of OA suggesting the possibility
that caspase inhibitors may have beneficial effects in
human OA183.
Summary: in-vitro studies suggest that caspase inhibition
does not always rescue cells from undergoing cell death
even in situations where caspase activation is involved. On
the other hand, some experimental models demonstrate
that caspase inhibition can lead to improved disease out-
come. Caspase inhibitors are potentially of therapeutic
value for the treatment of injury-induced OA.
Conclusion
Research on chondrocyte apoptosis has revealed a
histologic association between cell death and extracellular
matrix degradation. Mechanisms can be proposed (Fig. 4)
to explain how cell death and structural damage are linked
and contribute to the chronic matrix remodeling process
that characterizes OA. More research is required to fully
characterize the frequency and types of cell death in aging
and OA cartilage. Inducers of chondrocyte death and
Fig. 4. Linkage of cell death, inflammation, and matrix degradation. Cell death can lead to altered extracellular matrix structure and abnormal
mechanical function. Cytokines induce matrix metalloproteinases which generate matrix degradation products that can contribute to the
activation of catabolic responses in chondrocytes. Degraded cartilage matrix is also compromised in its survival promoting effects for
chondrocytes.
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intracellular signaling pathways are yet to be analyzed in
detail. Potential therapeutic applications of apoptosis inhi-
bition appear feasible and should be pursued for acute
cartilage injury as well as OA.
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